Tag: Clots
Peri-Op RBC Transfusions Linked to Postoperative VTE
Perioperative red blood cell transfusion linked to increased adjusted odds of VTE, DVT, PE
Rivaroxaban Linked to Low VTE Recurrence in Active Cancer
Lower rate of VTE recurrence, but higher clinically relevant non-major bleeding versus dalteparin
Lower Thromboembolic Risk With New A-Fib After CABG Versus NVAF
Thromboembolic risk lower for postoperative atrial fibrillation s/p CABG versus nonvalvular a-fib
Varicose Veins May Increase Likelihood of Blood Clots
Possible increased risk of pulmonary embolism, peripheral artery disease less clear
Safety of PERC Tool Validated for Very Low Risk PE Rule Out in ER
Eight-item, pulmonary embolism rule-out criteria safe for use with very low risk patients in ER
Increased Risk of Thrombosis in Myeloproliferative Neoplasms
Higher rates of thrombosis compared to matched controls; risk highest at and soon after diagnosis
Pharmacomechanical Thrombolysis No Benefit in DVT
Addition of pharmacomechanical catheter-directed thrombolysis resulted in higher risk of bleeding
No Increased Risks for DOAC Use Versus Warfarin in VTE
Direct oral anticoagulants not linked to increased risk of major bleeding, death in venous thromboembolism
Cancer Risk Up for RA Patients With Venous Thromboembolism
Risk of cancer increased during the first year after VTE and in longer follow-up period
Extended Thromboprophylaxis Safe, Effective After Liver Surgery
Severe complication rate 5.6 percent, with no 90-day mortalities
